Overview
Status
Active
Registry date
2024-09-26
Share capital
5,670,100.00 PLN
Registered address
ul. Gdańska 130/Iv piętro, 90-520 Łódź, Poland
Financials
Filing timeliness
No financial statement for 2026 – the filing deadline has passed. 1 of 1 financial statements was filed late (for 2025, 30 days late).
- 2026not filed
- 202514/11/2025
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 57.35kMedianUSD 1.06mAverageUSD 22.41m
Net profit
This companyUSD -158.79kMedianUSD 37.20kAverageUSD 879.46k
Operating costs
This companyUSD 215.62kMedianUSD 921.66kAverageUSD 21.08m
Assets
This companyUSD 372.67kMedianUSD 609.79kAverageUSD 11.85m
Industry
- Advertising (73.1)
Authorized Representatives
Achyuth Reddy Manne – Management Board Member
Samrat Kamdar – Management Board Member
Nikhil Reddy Mandha – Management Board Member
Manner of representation
Each member of the management board is authorised to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Msn Laboratories Private Limited | 156,718 | $1,531,631.55 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2024-11-01.
25 1030 1508 0000 0008 2401 2000
95 1030 1508 0000 0008 2401 2001
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Novama CloudS.A. | $8,295,437.50 | novama.cloud | ||
| Euroleki Gksp. z o.o. + limited partnership | $6,866,421.91 | euroleki.eu | ||
| Ana-Medsp. z o.o. | $5,202,905.16 | ana-med.eu | ||
| TDFS.A. | $5,168,316.22 | tdfsa.pl | ||
| Orthoactivesp. z o.o. | $617,449.08 | orthoactive.pl | ||
| CanpolandS.A. | $328,824.15 | canpoland.com | ||
| Geneco Groupsp. z o.o. | $156,220.50 | genecocontact.pl | ||
| Novaova Sosnowski Wadowskisp. k. | $54,452.69 | novaova.pl | ||
| Endolink PharmaS.A. | $7,191.18 | endolink.pl | ||
| Novaovasp. z o.o. | $0.16 | novaova.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-11-17 | Share capital increase (2,000,000.00 PLN → 5,670,100.00 PLN) | |
| 2024-09-26 | Entered in the register |
FAQ
The main business activity of MSN Laboratories Poland focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on September 26, 2024.
The headquarters is located at: ul. Gdańska 130, 90-520 Łódź.
The share capital of the company is PLN 5,670,100 (approx. $1.5 million).
The latest available financial statement covers the period from September 26, 2024 to March 31, 2025.
In 2025, the company's revenue reached $57,346.
No, in 2025 the company reported a net loss of $158,788.
The largest operating cost category falls under employee remuneration. This category amounted to $112,424 in 2025, representing 52% of all operating expenses.
Last updated: 2026-10-07